GlaxoSmithKline Pharmaceuticals informs about disclosure
In terms of Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, GlaxoSmithKline Pharmaceuticals has informed that the Board of Directors have jointly authorized the following personnel of the Company, for the purpose of determining the materiality of any event or transaction for the purpose of making disclosures to the Stock Exchange. 1. Bhushan Akshikar Managing Director. Email: - bhushan.2.akshikar@gsk.com. 2. Ronojit Biswas Whole- time Director & Chief Financial Officer: - Email:- ronojit.b.biswas@gsk.com. 3. Ajay Nadkarni Company Secretary Email: ajay.a.nadkarni@gsk.com. 4. Amit Pandey Head of Legal Email:- amit.g.pandey@gsk.com.
The above information is a part of company’s filings submitted to BSE.
